Fulgent Agrees to Buy Texas Testing Firm Inform Diagnostics for $170M, boosting its non-Covid testing business.

Learn more about Fulgent Genetics’ agreement to buy Texas testing firm Inform Diagnostics for $170 million, boosting its non-Covid testing business.

Related Keywords

New York ,United States ,Boston ,Massachusetts ,Phoenix ,Arizona ,Houston ,Texas ,Kevin Degeeter ,Ming Hsieh ,Temple Fulgent Genetics Inc ,Diagnostics Inc ,Oppenheimer Co ,Temple City Based Fulgent Genetics ,Texas Based Inform Diagnostics ,Avista Capital Partners ,New York City ,New York Based Oppenheimer ,Los Angeles County ,Inform Diagnostics ,Inform Diagnostic ,Inform Diagnostic Covid ,Covid Omicron ,